D-1502-2022 Class I Terminated
FDA drug recall D-1502-2022 was initiated by Vi-Jon, LLC on Jul 15, 2022 and is designated Class I. Reason for recall: Microbial contamination of non-sterile products. The recall status is terminated (terminated May 9, 2024). Affected quantity: 5,304 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 21, 2022
- Initiation Date
- Jul 15, 2022
- Termination Date
- May 9, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,304 bottles
Product description
EQUALINE magnesium citrate saline laxative, oral solution, (1.745 g/fl oz), DYE FREE lemon flavor, 10 FL OZ (296 mL), Distributed by Supervalu Inc. Eden Prairie, MN 55344 USA, or Distributed By UNFI Providence, RI 02908, NDC 41163-769-38 UPC 0 41163 50068 6
Reason for recall
Microbial contamination of non-sterile products.
Distribution pattern
Distributed Nationwide in the USA as well as Canada and Panama.
Code information
Lot # 0511629, EXP 12/4/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1502-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026